Proyectos de investigación
Comienza el contenido principal
Gene editing of key transcription factors to improve the antitumor efficacy of Adoptive T cell Therapy
18th national competition for scientific and technical research
Immunotherapy and cancer

Investigador Principal: Juan José Lasarte Sagastibelza
Abstract
The aim of this project was to introduce genetic modifications into T lymphocytes to give them a greater proliferative and antitumor capacity even in a hostile environment such as that found in tumors. The reprogramming of these lymphocytes, modulating the expression of different transcription factors that can modulate the state and activity of the lymphocytes, can improve their antitumor efficacy. We have found that the introduction of a gene encoding the EGF factor receptor, widely expressed in various types of tumors, increases the proliferative and antitumor capacity of T lymphocytes in adoptive transfer strategies.
Using CrisprCas9 technology, we have edited the Foxp3 gene [Foxp3down (dn)] in CD8 T lymphocytes and we have observed that such silencing worsens the antitumor response of CD8 T cells in adoptive cell transfer (ACT). In contrast, Foxp3 overexpression increases the antitumor efficacy of CD8 T lymphocytes. We have performed transcriptomic analysis of CD8 cells with silenced Foxp3 and with overexpressed Foxp3. Our data indicate that Foxp3 overexpression would favor differentiation towards memory cells and, on the contrary, Foxp3 editing would promote differentiation to effector cells. In the context of ACT, numerous studies indicate that memory T cells have a greater antitumor efficacy than effector cells. This would explain the behavior of the CD8 Foxp3UP and Foxp3dn T lymphocytes in antitumor efficacy experiments. Our data reveal a previously unknown role for Foxp3 in the regulation of CD8 T cell differentiation.
Scientific Production |
|
---|---|
Magazine Articles | 4 |
Communications at national conferences | 2 |
Communications at international conferences | 3 |
-
Actividades relacionadas
-
Proyectos relacionados
-
Noticias relacionadas
-
Publicaciones relacionadas
Actividades relacionadas
-
4
nov
2022
Session Red Nacional de Metástasis Cerebral (RENACER): Dos años de andadura conjunta. 2ª Asamblea general Madrid, Friday, 4 November 2022, 10:45 hours
-
16
mar
2023
Conference Nuevas estrategias contra el cáncer: poner el carro delante de los caballos Madrid, Thursday, 16 March 2023, 19:00 hours
-
18
may
2023
Session Riesgo cardiovascular en largos supervivientes de cáncer infantil Madrid, Thursday, 18 May 2023, 9:30 hours
Proyectos relacionados
- Transforming EGFR expressing tumors into immune-rejectable tissues Investigador Principal: Fernando Pastor Rodríguez
- Epigenetic regulation mediated by Ring1A/Ring1B, the ubiquitin ligases of the Polycomb system Investigador Principal: Miguel Ángel Vidal Caballero Centro de investigación o Institución: Centro de Investigaciones Biológicas (CSIC)
- Phototherapy: resonant gold nanoparticles in the near infrared for photothermal ablation of tumour cells and for activation of therapeutic genes Investigador Principal: Manuel Arruebo Gordo Centro de investigación o Institución: Institute of Nanoscience of Aragón. University of Zaragoza.
Noticias relacionadas
Publicaciones relacionadas


Fin del contenido principal